FDA.reportPublic FDA data

Application 210186

Type
ANDA
Sponsor
AMNEAL PHARMS NY

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OSELTAMIVIR PHOSPHATEOSELTAMIVIR PHOSPHATEFOR SUSPENSION;ORALEQ 6MG BASE/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42291-567Oseltamivir PhosphateOseltamivir PhosphateAvKARE, Inc.ANDACurrent
42291-567Oseltamivir PhosphateOseltamivir PhosphateAvKARE, Inc.ANDACurrent
42291-567Oseltamivir PhosphateOseltamivir PhosphateAvKARE, Inc.ANDACurrent
42291-567Oseltamivir PhosphateOseltamivir PhosphateAvKARE, IncANDACurrent
42291-567Oseltamivir PhosphateOseltamivir PhosphateAvKAREANDACurrent
42291-567Oseltamivir PhosphateOseltamivir PhosphateAvKAREANDACurrent
69238-1273Oseltamivir PhosphateOseltamivir PhosphateAmneal Pharmaceuticals NY LLCANDACurrent
69238-1273Oseltamivir PhosphateOseltamivir PhosphateAmneal Pharmaceuticals LLCANDACurrent
69238-1273Oseltamivir PhosphateOseltamivir PhosphateAmneal Pharmaceuticals NY LLCANDACurrent
69238-1273Oseltamivir PhosphateOseltamivir PhosphateAmneal Pharmaceuticals NY LLCANDACurrent
69238-1273Oseltamivir PhosphateOseltamivir PhosphateAmneal Pharmaceuticals NY LLCANDACurrent
69238-1273Oseltamivir PhosphateOseltamivir PhosphateAmneal Pharmaceuticals NY LLCANDACurrent